Physician profile
Michael Brucker
NPI 1710034467
$14,743.43
in general payments reported to CMS, 2019-2025
12 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $122 · 2021: $526 · 2022: $554 · 2023: $385 · 2024: $833 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,771.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11,193.20 | 2019-2022 | |
| Sientra, INC. | $1,144.49 | 2019-2022 | |
| Tela Bio, INC. | $1,027.70 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $578.96 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Motiva USA, LLC | $222.99 | 2024-2025 | |
| Merz North America, INC. | $221.36 | 2021-2025 | |
| W. L. Gore & Associates, INC. | $125.00 | 2019 | |
| Mentor Worldwide LLC | $87.36 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $42.88 | 2021 | |
| Apyx Medical Corporation | $42.66 | 2019-2020 | |
| Galderma Laboratories, L.P. | $35.41 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.42 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.